Interferon-α therapy for chronic myelogenous leukemia
- 31 October 1995
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 99 (4) , 402-411
- https://doi.org/10.1016/s0002-9343(99)80189-2
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.Journal of Clinical Investigation, 1994
- Combined Interferon Alfa-2a and Cytosine Arabinoside as First-Line Treatment for Chronic Myeloid LeukemiaActa Haematologica, 1993
- Use of Interferon Alfa-2a to Treat Hematologic Relapse of Chronic Myelogenous Leukemia after Bone Marrow TransplantationActa Haematologica, 1993
- Combination therapy with interferon alpha‐2b plus low‐dose interferon gamma in pretreated patients with Ph‐positive chronic myelogenous leukaemiaBritish Journal of Haematology, 1992
- Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantationEuropean Journal of Cancer and Clinical Oncology, 1991
- Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: Preliminary results of an open French multicentre randomized studyEuropean Journal of Cancer and Clinical Oncology, 1991
- Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primersBritish Journal of Haematology, 1990
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- Bone Marrow Transplantation for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1986